A Population Study: HLA-A, -B, -C, -DRB1, -DQB1, -DQA1 Alleles, and ABDR Haplotype Frequencies in the Aegean Region of Türkiye
PDF

Original Article

A Population Study: HLA-A, -B, -C, -DRB1, -DQB1, -DQA1 Alleles, and ABDR Haplotype Frequencies in the Aegean Region of Türkiye

Forbes J Med 2025;6(1):1-8 DOI: 10.4274/forbes.galenos.2024.50375
, , , , , ,
PDF
Permissions

Abstract

Objective

Human leukocyte anti-gen (HLA) molecules are vital molecules because they present foreign anti-gens to immune cells and trigger the immune response. Thus, they are associated with diseases, and they play crucial roles in solid organ transplantation and hematopoietic stem cell transplantation. This study aimed to determine the HLA allele and three-locus haplotype frequencies of the Turkish population. This is the first study in Türkiye to include such a large, sizable population.

Methods

The study included 6,039 bone marrow donors. Sequence-specific oligonucleotide probes and sequence-specific primers were employed for HLA typing. After excluding related individuals, 1222 A, 1229 B, 930 DRB1, 102 C, 227 DQB1, 163 DQA1 allele couples, and 336 ABDR haplotype couples were analyzed using Arlequin v3.5 Software and the R package programs. The results were compared with those from the border countries.

Results

The most frequently observed HLA alleles were A*02, B*35, C*07, DRB1*11, DQA1*01, and DQB1*03. The most prevalent ABDRB1 haplotype was A*24 B*35 DRB1*11 in our population. For all loci, the population was in Hardy-Weinberg equilibrium. A linkage disequilibrium analysis revealed a strong link between the A-B, A-DRB1, and B-DRB1 loci. The results of the two methods were similar.

Conclusion

These findings are consistent with populations in bordering nations. Our findings will support numerous therapeutic applications, including drug discovery, disease therapy, and organ transplantation. The Arlequin and R programs are suitable for analyses.

Keywords: HLA, allele frequency, haplotype frequency

INTRODUCTION

The human leukocyte anti-gen (HLA) gene on chromosome 6p21 encodes HLA molecules, which are cell surface proteins that are crucial for anti-gen presentation to T lymphocytes. HLA gene Regions are the most polymorphic on the human genome, and HLA molecules expressed from these Regions play critical roles in the immune system. HLA is divided into two classes: HLA Class 1 (HLA-A, HLA-B, and HLA-C) and HLA Class 2 (HLA-DR, HLA-DQ, and HLA-DP). Type 1 HLA molecules present the anti-genic peptides to CD8+ T-cells, whereas type 2 HLA molecules present the anti-genic peptides to CD4+ T-cells.

HLA typing is commonly used in clinics for hematopoietic stem cell and solid organ transplantation. Furthermore, because of its roles in immune response, it is linked to a variety of diseases. Thus, community-based studies on HLA allele frequency may be valuable for detecting genetic variation and population origin, identifying vaccine-safe epitopes, and discovering disease associations. These studies also aid in the creation of HLA databases. The frequencies of alleles and haplotypes in various populations have been the subject of numerous studies. Research conducted both nationally and internationally has linked specific alleles to distinct clinical symptoms.

The Hardy-Weinberg equilibrium (HWE) and linkage disequilibrium (LD) are essential concepts in population genetics that explain genetic diversity and inheritance patterns. HWE establishes a standard for forecasting genotype frequencies in a static population, whereas LD assesses the non-random correlation of alleles across several loci. Collectively, they provide insights into genetic composition and evolutionary mechanisms. Deviations from HWE may signify genotyping inaccuracies or the existence of uncommon variations, especially within extensive genomic datasets. LD quantifies the extent to which alleles at distinct loci are co-inherited, influenced by factors including population structure and selection. The precise measurement of LDs is essential for applications such as disease association studies, and novel approaches have enhanced LD estimation under HWE conditions. The correlation between HWE and LD was significant, as variations from HWE might influence LD assessments and hence confound genetic investigations.

In this study, we investigated the frequencies of alleles and haplotypes in bone marrow (BM) donors. We compared the most frequently observed alleles and haplotypes with those from neighboring nations. Furthermore, we evaluated two statistical tools (Arlequin and R) to analyze the data.

METHODS

Samples

Molecular HLA typing data from 6039 healthy Turkish people were retrospectively analyzed. Between 2009 and 2018, these individuals were BM donors who applied to the tissue typing laboratory at the hospital. Related individuals were excluded to ensure that genetic variation was assessed objectively and in a population-representative manner. In total, 1222 A, 1229 B, 930 DRB1, 102 C, 227 DQB1, 163 DQA1 allele couples, and 336 ABDR haplotype couples were analyzed. The results were compared with those from bordering countries.

Informed consent was provided by all patients. In accordance with the Declaration of Helsinki, our İzmir Katip Çelebi University Non-interventional Clinical Research Ethics Committee approved the study (decision no: 0097, date: 23.03.2023).

Molecular Human Leukocyte Anti-gen Typing

Sequence-specific oligonucleotide probe (SSOP) and sequence-specific primer (SSP) methods were used for the molecular typing of HLA. Deoxyribonucleic acid (DNA) was isolated using an EZ1 DNA Blood Kit (Qiagen, Hilden, Germany) via an automatic system (Geno M-6, Qiagen). Commercial SSOP (Lifecodes, Rodermark, Germany) and SSP kits (Olerup, Stockholm, Sweden) were used for the procedures. The tests were performed according to the manufacturer’s instructions. Briefly, the Regions were amplified by polymerase chain reaction (PCR), and the amplicons were hybridized with specific probes for the SSOP method. The results were analyzed using a Luminex fluoroanalyzer. For the SSP method, samples were amplified using SSPs by PCR, and the amplicons were evaluated on agarose gels using score software.

Statistical Analysis

All statistical analyses, including total allele frequencies, haplotype frequencies LD, and HWE tests, were conducted using R 4.2 programming language with the pegas and adagen packages, and Arlequin v3.5.-

R is a robust and versatile programming language and software environment, specifically designed for statistical analysis, data science, and visualization. Arlequin, on the other hand, is a software specifically designed for the examination and interpretation of genetic data. The tool provides a diverse range of statistical methodologies and tests to facilitate the comprehension of genetic population structure, genetic diversity, and demographic history. The congruent outcomes of these two systems are of significant importance for their application, particularly in the analysis of HLA allele and haplotype frequencies. This comparison enables the assessment of the trade-offs between a versatile, general-purpose tool like R and a specialized software platform for population genetics such as Arlequin. This facilitated the identification of the most efficient, precise, and user-centric method for evaluating HLA allele and haplotype frequencies in our study.

RESULTS

In total, 19 different HLA-A, 28 different HLA-B, 14 different HLA-C, 13 different HLA-DRB1, 6 different HLA-DQA1, and 5 different HLA-DQB1 alleles were identified. The allele with the highest frequency was HLA-A*02 [allele frequency (AF): 0.195990], followed by HLA-A*24, HLA-A*03, HLA-A*01, and HLA-A*11 (AF: 0.147709, 0.126432, 0.119885, and 0.087561), respectively. The five initial HLA-B alleles that were most frequently found were HLA-B*35, HLA-B*51, HLA-B*44, HLA-B*18, and HLA-B*38 (AF: 0.174938, 0.128152, 0.080146, 0.064279, and 0.049227), respectively. The first five frequently observed HLA-C alleles were HLA-C*07, HLA-C*04, HLA-C*12, HLA-C*15, and HLA-C*06 (AF: 0.230392, 0.137254, 0.112745, 0.102941, and 0.083333), respectively.

The highest frequency was HLA-DRB1*11 (AF: 0.229569). Subsequently, HLA-DRB1*04 (AF: 0.147311), HLA-DRB1*15 (AF: 0.110215), HLA-DRB1*03 (AF: 0.095698), and HLA-DRB1*13 (AF: 0.093010). The most common first five HLA-DQA1 alleles were HLA-DQA1*01, HLA-DQA1*05, HLA-DQA1*03, HLA-DQA1*02, and HLA-DQA1*04 (AF: 0.365030, 0.325153, 0.193251, 0.098159, and 0.012269), respectively. The most frequently observed HLA-DQB1 allele was HLA-DQB1*03 (AF: 0.458149), followed by HLA-DQB1*05 (AF: 0.202643), -DQB1*06 (AF: 0.178414), -DQB1*02 (AF: 0.145374), and -DQB1*04 (AF: 0.015418). We found the same ratios using the R program ().

Table 1. Allele frequencies of HLA-A, -B, and -DRB1 by R package degener and Arlequin v.3.5 software

HLA-A allele

AF

n

HLA-B allele

AF

n

HLA-C allele

AF

n

HLA-DRB1 allele

AF

n

HLA-DQA1 allele

AF

n

HLA-DQB1 allele

AF

n

A*01

0.119885

293

B*07

0.04882

120

C*01

0.029412

6

DRB1*01

0.063441

118

DQA1*01

0.365031

119

DQB1*02

0.145374

66

A*02

0.195990

479

B*08

0.045566

112

C*02

0.063725

13

DRB1*03

0.095699

178

DQA1*02

0.09816

32

DQB1*03

0.45815

208

A*03

0.126432

309

B*13

0.034988

86

C*03

0.058824

12

DRB1*04

0.147312

274

DQA1*03

0.193252

63

DQB1*04

0.015419

7

A*11

0.087561

214

B*14

0.019121

47

C*04

0.137255

28

DRB1*07

0.082796

154

DQA1*04

0.01227

4

DQB1*05

0.202643

92

A*23

0.03477

85

B*15

0.036208

89

C*05

0.029412

6

DRB1*08

0.018817

35

DQA1*05

0.325153

106

DQB1*06

0.178414

81

A*24

0.147708

361

B*18

0.06428

158

C*06

0.083333

17

DRB1*09

0.008065

15

DQA1*06

0.006135

2

In total

454

A*25

0.004909

12

B*27

0.025224

62

C*07

0.230392

47

DRB1*10

0.020968

39

In total

326

-

-

-

A*26

0.063829

156

B*35

0.174939

430

C*08

0.02451

5

DRB1*11

0.22957

427

-

-

-

-

-

-

A*29

0.029869

73

B*37

0.013426

33

C*12

0.112745

23

DRB1*12

0.012903

24

-

-

-

-

-

-

A*30

0.038052

93

B*38

0.049227

121

C*14

0.02451

5

DRB1*13

0.093011

173

-

-

-

-

-

-

A*31

0.018412

45

B*39

0.013832

34

C*15

0.102941

21

DRB1*14

0.066129

123

-

-

-

-

-

-

A*32

0.045008

110

B*40

0.032954

81

C*16

0.068627

14

DRB1*15

0.110215

205

-

-

-

-

-

-

A*33

0.025777

63

B*41

0.019528

48

C*17

0.029412

6

DRB1*16

0.051075

95

-

-

-

-

-

-

A*34

0.002454

6

B*42

0.000407

1

C*18

0.004902

1

In total

1860

-

-

-

-

-

-

A*66

0.003682

9

B*44

0.080146

197

In total

204

-

-

-

-

-

-

-

-

-

A*68

0.041734

102

B*45

0.002848

7

-

-

-

-

-

-

-

-

-

-

-

-

A*69

0.011047

27

B*46

0.004068

10

-

-

-

-

-

-

-

-

-

-

-

-

A*74

0.002454

6

B*47

0.002034

5

-

-

-

-

-

-

-

-

-

-

-

-

A*80

0.000409

1

B*48

0.002848

7

-

-

-

-

-

-

-

-

-

-

-

-

In total

2444

B*49

0.038649

95

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

B*50

0.031326

77

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

B*51

0.128153

315

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

B*52

0.037022

91

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

B*53

0.009764

24

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

B*54

0.002034

5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

B*55

0.036208

89

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

B*56

0.002848

7

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

B*57

0.021562

53

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

B*58

0.019935

49

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

B*73

0.002034

5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

In total

2458

-

-

-

-

-

-

-

-

-

-

-

-

HLA: Human leukocyte anti-gen, AF: Allele frequency; n: Number of samples

We analyzed the frequencies of 336 three-locus haplotypes. Our population was in HWE for all loci using the two methods (). The haplotype frequencies were similar between the two methods. The most prevalent haplotype in our population was A*03 B*44 DRB1*04 had the highest frequency ().

Table 2. Data table of Hardy-Weinberg equilibrium analysis using the two statistical tools

Locus

Genotypes

Obs heterozygosity

Exp heterozygosity

p value

SD

By Arlequin v.3.5.

HLA-A

336

0.88657

0.88908

0.14043

0.00028

HLA-B

336

0.90149

0.92466

0.13648

0.00020

HLA-DRB1

336

0.85672

0.88705

0.33734

0.00054

The R tool

HLA-A

336

0.88922

0.88782

0.1568

0.017268

HLA-B

336

0.90419

0.92290

0.1622

0.014596

HLA-DRB1

336

0.85928

0.88536

0.4

0.01732

Genotypes: Number of genotypes, Obs: Observed, Exp: Expected, p value: p value for the deviation of HWE, SD: Standard deviation, HLA: Human leukocyte anti-gen

Table 3. HLA three-locus haplotype frequency analysis using R and Arlequin tools

Haplotype

n

Frequency

A*03 B*44 DRB1*04

11

0.016467

A*11, B*35, DRB1*14

A*02 B*51 DRB1*11

10

0.01497

A*33 B*14 DRB1*01

A*23 B*49 DRB1*11

9

0.013473

A*24 B*35 DRB1*11

8

0.011976

A*26 B*38 DRB1*13

7

0.010479

n: Number of samples, HF: Haplotype frequency, HLA: Human leukocyte anti-gen

The LD analysis was performed using only the Arlequin software program. According to our LD analysis, there was a significantly strong association between A-B, A-DRB1, and B-DRB1 loci (p<0.001) ().

Table 4. Three-loci Linkage disequilibrium estimation by Arlequin software

Haplotype

D’

p value

Chi-square test values

DF

A-B

0.99990

<0.0001

616.5

432

A-DRB1

0.99990

0.00050

263

192

B-DRB1

0.99921

<0.0001

612.6

324

p<0.05 values were accepted as significant.

D’: Perfect linkage disequilibrium values, DF: Degrees of freedom

DISCUSSION

In this study, we evaluated HLA allele and haplotype frequencies in the Aegean Region of the Turkish population. This is the first study conducted in the Aegean Region of Türkiye and the first to evaluate the HLA allele and haplotype frequencies of a large Turkish population. In addition, we also compared the two statistical methods for HLA allele and haplotype analyses.

In our study population, the most common HLA-A allele frequency was A*02, followed by A*24. The top two alleles were the same in various Turkish populations, including Greece, Bulgaria, Georgia, and in Iran.- However, only the top allele was the same in the Armenian population. The compatibility of the population in the Aegean Region with surrounding countries may be attributed to past migration. We found that the two most frequently observed HLA-B alleles were B*35 and B*51. The HLA-B alleles with the highest frequencies (AF: 0.18) were B*05 and B*35 in the Iranian population.

The outcomes were comparable for different Turkish populations, Armenia, Georgia, Iran, and Bulgaria.15-17,19-22 In the Greek and Turkish populations, the most common allele was HLA-B*51, followed by B*35., This discrepancy may be attributable to their geographic location. While the most frequent alleles may differ, the predominant B alleles are consistent among populations in the Greek and Aegean Regions. The migration of individuals from Greece and Bulgaria to Türkiye, particularly to the Aegean Region, has played a significant role in fostering diversity throughout history.

The most common HLA-C alleles were HLA-C*07 and HLA-C*04, respectively, in our study cohort. However, the results were contrary in the Syrian and Greek populations., The most common two alleles were HLA-C*12 and C*07 in the Iranian population. The difference in the most common allele may be due to the location of Iran in the Eastern Anatolia Region of Türkiye because our study cohort included the Aegean Region of Türkiye. Despite the replacement of the two most prevalent C alleles in the Greek and Syrian populations, these alleles remained identical to those found in the nations from which the immigrants originated. Due to the significant migration from Syria to the Aegean Region in recent times, the allele frequencies in the population have become comparable. HLA-DRB1*11 and DRB1*04 had the highest frequencies in our study group, respectively. The results were in accordance with previous Turkish population studies and in Syrian population.15-17,23 However, the only highest frequency was the same in border countries as observed in DRB1*11 and DRB1*15 in Armenian and Iranian populations, in DRB1*11 and DRB1*13 in Georgian populations, and in DRB1*11 and DRB1*16 in Greek populations., - It seems that at least one DRB1 allele is identical to those found in nearby nations. This is contingent on the historical migration patterns of adjacent nations. Among the HLA-DQA1 alleles, our results were similar in the Iranian population. However, we could not compare our results with other studies on border populations because the DQA1 locus was not investigated in these studies. The most frequently observed HLA-DQB1 alleles were similar in Iranian, Georgian, Greek, and in other Turkish population studies., , ,

We also evaluated the three-locus haplotype frequencies of ABDRB1 in our population. The most common haplotype differed from Iranian, Armenian, and Georgian populations.- Our most prevalent haplotype frequency was also different from another Turkish population in Central Anatolia. It is unsurprising that it is identical to the Greek population. These populations have coexisted for ages and have mutually contributed to genetic variety. HLA-A*02, B*35, C*07, DRB1*03, and DQB1*03 were the most common alleles in various Caucasian populations.- Accordingly, this population may have an ancestral relationship with Caucasians. When we considered distant populations, the HLA allele frequencies were related to the Lebanese, Vietnamese, Argentinian, Kazakhstani Russian, Maltese, and Korean populations.- The similarity of our HLA allele and haplotype frequencies with other populations can be attributed to historical migrations, genetic admixtures, shared environmental stresses, and evolutionary mechanisms. The balancing selection mechanism and geographical proximity were the primary factors that contributed to these similar characteristics.

The correlation between HLA allele and haplotype frequencies and illness risk is intricate and diverse, as demonstrated by numerous studies. The HLA area is essential for immunological response, with certain alleles potentially enhancing disease susceptibility or providing protection. The interaction is emphasized by the detection of many connections between HLA variants and various autoimmune and infectious illnesses. HLA haplotypes exhibit pleiotropic correlations with numerous diseases, suggesting that certain alleles can continuously affect the risk of different diseases. For example, HLA-B*08:01 and DRB1*03:01 are strongly correlated with Graves’ disease, although other alleles such as HLA-B*07:02 have protective benefits. HLA genes are associated with more than 100 disorders, including multiple sclerosis and type 1 diabetes, in which particular alleles may elevate or diminish disease risk. Recent research indicates that multiple sclerosis is linked to DRB1 and DQB1 alleles, which are prevalent in our country. A further study conducted in Russia revealed that the prevalent HLA-C, -DRB1, and -DQB1 alleles in the country were correlated with rheumatoid arthritis, type 1 diabetes, and psoriasis.

The small variations between the two methods for HWE analysis may be due to rounding during the calculation stage. However, these variations are minimal and have no impact on the p value’s significance. Both R and Arlequin are capable of performing HLA allele and haplotype frequency, HW, and LD analyses, but they cater to different user needs and expertise levels. Arlequin is a specialized population genetics tool with user-friendly interface. This makes it accessible to researchers with limited programming experience because analyses can be performed with minimal technical input. In contrast, R is a versatile statistical platform that requires additional packages (e.g., genetics, haplo.stats, or LDheatmap). Although this approach offers significant flexibility and allows for the customization of analysis pipelines, it requires advanced programming skills and familiarity with statistical methods. For researchers who are not proficient in R, the learning curve is steep, potentially limiting its immediate usability for LD analysis. Despite these challenges, R’s open-source nature and ability to integrate diverse statistical functions makes it an attractive option for experienced users seeking a tailored analytical workflow. By contrast, Arlequin provides an out-of-the-box solution for researchers focusing on LD and other population genetics metrics, particularly when ease of use is a priority.

Study Limitations

Although our study includes a large cohort of BM donors, it may not fully represent the entire genetic diversity of the Turkish population, as the donors were primarily selected from a specific registry. While we analyzed multiple HLA loci, some additional loci (e.g., HLA-DP) were not included, which could provide further insights into genetic associations and disease susceptibility. Although we compared our results with populations from bordering countries, differences in sampling methodologies and HLA typing techniques could influence the comparability of the findings.

CONCLUSION

In conclusion, we found that, as expected, the frequencies of the HLA alleles were comparable between the bordering countries. Despite the similarities in allele frequencies, the haplotype frequencies were dissimilar. Knowing a population’s allele and haplotype frequencies is crucial for understanding its relationships to transplantation, disease resistance, and therapeutic development. Our findings may assist clinicians in diagnosing disorders, planning transplantation, and creating new medications. Furthermore, numerous statistics software tools are employed to determine allele and haplotype frequencies. Our results show the use of the two Arlequin and R statistical programs to analyze HLA diversity.

Footnotes

Ethics

Ethics Committee Approval: The study was conducted with the permission of İzmir Katip Çelebi University Non-interventional Clinical Research Ethics Committee approved the study (decision no: 0097, date: 23.03.2023).

Informed Consent: Informed consent was provided by all patients.

Authorship Contributions

Concept: A.Ö.K., T.K.A., İ.P., Design: T.K.A., R.D.G., İ.P., Data Collection or Processing: A.Ö.K., M.S., B.Ç.A., R.D.G., D.İ.T., Analysis or Interpretation: A.Ö.K., T.K.A., M.S., D.İ.T., Literature Search: A.Ö.K., T.K.A., M.S., B.Ç.A., Writing: A.Ö.K.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study received no financial support.

References

1

Satapornpong P, Jinda P, Jantararoungtong T, et al. Genetic diversity of HLA class I and class II alleles in Thai populations: contribution to genotype-guided therapeutics. Front Pharmacol. 2020;11:78.

2

Varzi AM, Shahsavar F, Tarrahi MJ. Distribution of HLA-DRB1 and HLA-DQB1 alleles in Lak population of Iran. Hum Immunol. 2016;77:580-3.

3

Ikhtiar AM, Jazairi B, Khansa I, Othman A. HLA class i alleles frequencies in the Syrian population. BMC Res Notes. 2018;11:324.

4

Crux NB, Elahi S. Human leukocyte antigen (HLA) and immune regulation: how do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections? Front Immunol. 2017;8:832.

5

Patel JS, Patel MM, Koringa PG, et al. Human leukocyte antigen alleles, genotypes and haplotypes frequencies in renal transplant donors and recipients from West Central India. Indian J Hum Genet. 2013;19:219-32.

6

Patıroğlu T, Akar HH. The frequency of HLA-A, HLA-B, and HLA-DRB1 alleles in patients with acute lymphoblastic leukemia in the Turkish population: a case-control study. Turk J Hematol. 2016;33:339-45.

7

Neamatzadeh H, Dastgheib SA, Mazaheri M, et al. Hardy-Weinberg equilibrium in meta-analysis studies and large-scale genomic sequencing era. Asian Pac J Cancer Prev. 2024;25:2229-35.

8

Abramovs N, Brass A, Tassabehji M. Hardy-Weinberg equilibrium in the large scale genomic sequencing era. Front Genet. 2020;11:210.

9

Hui TYJ, Burt A. Estimating linkage disequilibrium from genotypes under Hardy-Weinberg equilibrium. BMC Genet. 2020;21:21.

10

Anonymous. R: The R project for statistical computing. n.d. Last Accessed Date: 11/22/2024. Available from: https://www.r-project.org/

11

Jombart T. adegenet: a R package for the multivariate analysis of genetic markers. Bioinformatics. 2008;24:1403-5.

12

Paradis E. pegas: an R package for population genetics with an integrated-modular approach. Bioinformatics. 2010;26:419-20.

13

Arrieta-Bolaños E, Hernández-Zaragoza DI, Barquera R. An HLA map of the world: a comparison of HLA frequencies in 200 worldwide populations reveals diverse patterns for class I and class II. Front Genet. 2023;14:866407.

14

Arnaiz-Villena A, Karin M, Bendikuze N, et al. HLA alleles and haplotypes in the Turkish population: relatedness to Kurds, Armenians and other Mediterraneans. Tissue Antigens. 2001;57:308-17.

15

Kayhan B, Kurtoglu EL, Taskapan H, et al. HLA-A, -B, -DRB1 allele and haplotype frequencies and comparison with blood group antigens in dialysis patients in the East Anatolia region of Turkey. Transplant Proc. 2013;45:2123-8.

16

Uyar FA, Dorak MT, Saruhan-Direskeneli G. Human leukocyte antigen-A, -B and -C alleles and human leukocyte antigen haplotypes in Turkey: relationship to other populations. Tissue Antigens. 2004;64:180-7.

17

Uygun DFK, Özbay M, Sallakcı N, et al. Human leukocyte antigen frequencies in highly sensitized patients. Turkish J Immunol. 2015;3:11-4.

18

Latsoudis H, Stylianakis E, Mavroudi I, et al. Significance of regional population HLA immunogenetic datasets in the efficacy of umbilical cord blood banks and marrow donor registries: a study of Cretan HLA genetic diversity. Cytotherapy. 2022;24:183-92.

19

Ivanova M, Spassova P, Michailova A, Naumova E. Distributions of HLA class I alleles and haplotypes in Bulgarians-contribution to understanding the origin of the population. Tissue Antigens. 2001;57:208-15.

20

Rey D, Areces C, Alonso-Rubio J, et al. HLA in Georgians (Caucasus) and their relationship with Eastern Mediterraneans. Mol Biol Rep. 2013;40:5523-30.

21

Abedini F, Rahmanian N, Heidari Z, Feizi A, Sherkat R, Rezaei M. Diversity of HLA class I and class II alleles in Iran populations: systematic review and meta-analysis. Transpl Immunol. 2021;69:101472.

22

Matevosyan L, Chattopadhyay S, Madelian V, et al. HLA-A, HLA-B, and HLA-DRB1 allele distribution in a large Armenian population sample. Tissue Antigens. 2011;78:21-30.

23

Jazairi B, Khansaa I, Ikhtiar A, Murad H. Frequency of HLA-DRB1 and HLA-DQB1 alleles and haplotype association in Syrian population. Immunol Invest. 2016;45:172-9.

24

Yantır E, Gündüz E, Çolak E. HLA alleles, genotype and haplotype analyzes from central Anatolia Region of Turkey. Balkan Med J. 2023;40:358-66.

25

Salvadori L de C, Santana FC de S, Marcos EVC. Frequency of alleles and haplotypes of the human leukocyte antigen system in Bauru, São Paulo, Brazil. Rev Bras Hematol Hemoter. 2014;36:108-14.

26

Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernández-Viña MA. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol. 2001;62:1009-30.

27

Louzada-Junior P, Smith AG, Hansen JA, Donadi EA. HLA-DRB1 and -DQB1 alleles in the Brazilian population of the northeastern region of the state of São Paulo. Tissue Antigens. 2001;57:158-62.

28

Jawdat D, Uyar FA, Alaskar A, Müller CR, Hajeer A. HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1 allele and haplotype frequencies of 28,927 Saudi Stem cell donors typed by next-generation sequencing. Front Immunol. 2020;11:544768.

29

Almawi WY, Nemr R, Finan RR, Saldhana FL, Hajjej A. HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in Lebanese and their relatedness to neighboring and distant populations. BMC Genomics. 2022;23:456.

30

Que TN, Khanh NB, Khanh BQ, et al. Allele and haplotype frequencies of HLA-A, -B, -C, and -DRB1 Genes in 3,750 cord blood units from a Kinh Vietnamese population. Front Immunol. 2022;13:875283.

31

Navello M, Müller MC, Riboldi MC, et al. Allele, genotype and haplotype frequencies of the HLA system in the province of Neuquén, Argentina. Transplantation. 2022;(9S):S566. Available from: https://cm.tts2022.org/webapp/lecture/1131

32

Hajjej A, Abdrakhmanova S, Turganbekova A, Almawi WY. HLA allele and haplotype frequencies in Kazakhstani Russians and their relationship with other populations. HLA. 2023;101:249-61.

33

Micallef S, Buttigieg J. #5950 Major HLA allele and haplotype frequencıes in the Maltese kidney transplant registry. Nephrol Dial Transplant. 2023;(Supplement_1).

34

Jung K, Kim JG, Shin S, Roh EY, Hong YJ, Song EY. Allele and haplotype frequencies of 11 HLA loci in Koreans by next-generation sequencing. HLA. 2023;101:602-12.

35

Smith CJ, Strausz S; FinnGen; Spence JP, Ollila HM, Pritchard JK. Haplotype analysis reveals pleiotropic disease associations in the HLA region. medRxiv. 2024;24311183.

36

Zawadzka-Starczewska K, Tymoniuk B, Stasiak B, Lewiński A, Stasiak M. Actual associations between HLA haplotype and graves’ disease development. J Clin Med. 2022;11:2492.

37

AL-Khaliq IMA. The relation between human leukocyte antigen and multiple sclerosis. SARJMS. 2024;6:54-5.

38

Kazakova P, Smirnova NV, Mitrofanov SI, et al. Study of HLA allele frequencies associated with autoimmune diseases in the population of the russian federation. SSRN Electronic Journal 2022; Available at SSRN: https://ssrn.com/abstract=4113797 or http://dx.doi.org/10.2139/ssrn.411379.